LFCR

Dopo l'orario di chiusura: 6.61 0.07 +1.07%

Lifecore Biomedical Inc (LFCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1064)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

Prossima data di guadagno

Ultimi documenti SEC

LFCR's Discussions on Twitter

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LFCR Lifecore Biomedical Inc	6.54	158.98M	147.12M	-33.88M	-13.62M	-0.4805
TAK Takeda Pharmaceutical Co Adr	17.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.53	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.80	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	69.69	29.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.70	20.39B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-17	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-09-04	Iniziato	KeyBanc Capital Markets	Sector Weight
2025-05-21	Iniziato	William Blair	Outperform
2024-09-05	Iniziato	Craig Hallum	Buy
2024-08-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2023-03-20	Downgrade	Stephens	Overweight → Equal-Weight

Mostra tutto

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Invest - The National Law Review

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ) - Supply Chain Digital

Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc.LFCR - Business Wire

Votes against certain rival proposals are part of Wynnefield's merger pledge at Lifecore Biomedical (LFCR). - Stock Titan

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR) - PR Newswire

Law firm probes Lifecore Biomedical board over possible unfair sale to Webster Equity Partners. - Pluang

Lifecore Biomedical: Bid Is Underwhelming (NASDAQ:LFCR) - Seeking Alpha

Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News - Investorideas.com

Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com Nigeria

3 Firms Lead $663.7M Lifecore Biomedical Take-Private Deal - law360.com

A $6.28-a-share merger gets a voting pledge from Legion Partners at Lifecore Biomedical (LFCR). - Stock Titan

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold. - Pluang

LFCR Downgraded by William Blair -- Rating Changed to Market Per - GuruFocus

LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC. - Morningstar

LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

Lifecore Biomedical to Go Private in Webster Buyout - TipRanks

Form 8K Lifecore Biomedical Inc For: 28 September By Investing.com - Investing.com Nigeria

Lifecore Biomedical to Be Acquired by Webster Equity Partners for Up to $663 Million - Yahoo Finance

Webster Equity Partners to acquire Lifecore for up to $663.7m - Investing.com

Lifecore Biomedical to Be Taken Private by Webster Affiliates in $6.28-Per-Share Cash Deal Plus CVR - TradingView

Webster Equity Partners to acquire Lifecore for up to $663.7m By Investing.com - Investing.com Canada

Lifecore Biomedical to be acquired by Webster Equity Partners - TradingView

A 49.5% premium is built into Lifecore Biomedical’s (LFCR) proposed sale. The cash price is only part of the deal. - Stock Titan

Lifecore Biomedical to be Acquired by Webster Equity Partners - GlobeNewswire

Lifecore Biomedical, Inc. (LFCR) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Lifecore Biomedical (LFCR) Short Interest & Short Float | Updated Sep 2026 $LFCR - MarketBeat

Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business (NASDAQ:LFCR) - Seeking Alpha

Lifecore plans customer meetings in Milan this October - Stock Titan

Lifecore Biomedical to Participate at CPHI Global Conference - GlobeNewswire

Lifecore Strikes Tech Transfer Deal for Commercial Manufacturing of Major Pharma Company Injectable - Contract Pharma

Lifecore Biomedical Signs New Commercial Transfer Agreement for Marketed Injectable Product - Quiver Quantitative

A marketed injectable drug is expected to bring Lifecore revenue in 2028. - Stock Titan

LFCR Q2 2026 Earnings: Narrower Loss of -$0.19 Beats Estimates, Shares Dip 1.35%Revenue Guidance Update - vinanet.vn

Lifecore (LFCR) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Session Move: Shares Rise 0.22% at the CloseEarnings Season Preview - vinanet.vn

Lifecore (LFCR) Earnings Reading: EPS Prints Above Forecast at the Close; After Results: Shares Move 2.42% Down on the DayGuidance Downgrade Alert - vinanet.vn

LFCR | Lifecore Biomedical, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative

Lifecore Biomedical Earnings Call Balances Growth and Strain - TipRanks

Lifecore (LFCR) Quarterly Scorecard: EPS Beats Its Estimate; The Stock Records a 1.83% Increase on the DayROA Comparison - vinanet.vn

Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - AOL.com

Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity - Yahoo Finance

Avoiding Lag: Real-Time Signals in (LFCR) Movement - news.stocktradersdaily.com

LFCR Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 16.59% EPS SurpriseAnalyst Coverage Count - vinanet.vn

Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerSell Signal Alerts - vinanet.vn

LFCR Q2 2026 Earnings: Narrower-than-Expected Loss Offers Modest EncouragementGuidance vs Actual - vinanet.vn

Judge approves $3.75 million Lifecore investor settlement - Minnesota Lawyer

William Blair Maintains Lifecore Biomedical(LFCR.US) With Buy Rating - Moomoo

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - marketscreener.com

Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Discipline and Rules-Based Execution in LFCR Response - Stock Traders Daily

Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com Canada

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LFCR